je.st
news
Tag: multiple
Responses Observed in Three-Quarters of Heavily Pre-Treated Multiple Myeloma Patients Receiving KEYTRUDA (pembrolizumab) Combined With Lenalidomide and Dexamethasone
2015-12-07 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Findings Presented at the 57th American Society of Hematology Annual Meeting Demonstrate Activity of KEYTRUDA Therapy in Previously-Treated Multiple Myeloma Patients When Combined with Lenalidomide and Dexamethasone KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today new study findings investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in combination with lenalidomide and low-dose dexamethasone (two commonly used treatments for multiple myeloma) in patients whose disease has progressed after at least two lines of prior therapy, including a proteasome inhibitor and an IMiD (immune modulatory drug). Language: English Contact: Media:Pamela Eisele, 267-305-3558orKim Hamilton, 908-391-0131orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: multiple
combined
observed
receiving
New Company, DMW&H, Will Deliver Material Handling Innovation to Multiple Industries
2015-12-03 11:31:09| Industrial Newsroom - All News for Today
Carlstadt, NJ W and H Systems, Inc., a full-service integrator of material handling systems, announces that the company has been acquired by Dearborn Mid-West Company. WH will be integrated into Dearborn Mid-Wests Material Handling Systems Division and will collectively be rebranded DMW&H. The combined...
Tags: company
material
multiple
handling
Sosei Subsidiary Heptares Enters Strategic Drug Discovery Collaboration With Pfizer Inc. Focused On GPCR Targets Across Multiple Therapeutic Areas
2015-12-02 01:37:23| drugdiscoveryonline Home Page
Sosei Group Corporation (“Sosei”) recently announces that its wholly-owned subsidiary, Heptares Therapeutics has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas
Tags: areas
multiple
drug
focused
Quaker Chemical Launches Multiple Language Websites for QUINTOLUBRIC Fire-Resistant Hydraulic Fluids
2015-12-01 11:31:06| Industrial Newsroom - All News for Today
CONSHOHOCKEN, Penn. - Today, Quaker Chemical Corporation ("Quaker") (NYSE: KWR), a global provider of process fluids, chemical specialties and technical expertise, is debuting its website http://www.quintolubric.com for its QUINTOLUBRIC fire-resistant hydraulic fluids translated into seven additional...
Tags: language
multiple
websites
chemical
908 Devices Recognized With Multiple Industry Awards For M908 The World's First Handheld Mass Spectrometer
2015-11-24 07:04:15| chemicalonline Home Page
908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, is honored to announce that it has won three prestigious industry awards that honor innovation and technological prowess.
Tags: industry
multiple
awards
mass
Sites : [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] next »